What Seaport Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 2 |
| Sells | 0 | 0 |
| Total trades | 1 | 15 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 13,000 | 25,566,137 |
| Disposed | 0 | 0 |
| Net activity | +13,000 | +25,566,137 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hombach Robert J. | Director | Jun 22 | Open-market buy · P | +13,000 | $18.14 | +$236K | 13,000 |
| Healy James | Director | May 04 | Derivative Conversion · C | +804,379 | — | — | 2,731,538 |
| Healy James | Director | May 04 | Derivative Conversion · C | +1,927,159 | — | — | 1,927,159 |
| Loebel Antony | Chief Medical Officer | May 04 | Derivative Conversion · C | +20,109 | — | — | 20,109 |
| Arch Venture Partners XII, Llc | 10% owner | May 04 | Open-market buy · P | +1,100,000 | $18.00 | +$19.8M | 6,294,951 |
| Arch Venture Partners XII, Llc | 10% owner | May 04 | Derivative Conversion · C | +2,681,265 | — | — | 5,194,951 |
| Arch Venture Partners XII, Llc | 10% owner | May 04 | Derivative Conversion · C | +2,513,686 | — | — | 2,513,686 |
| Paul Steven M | Director | May 04 | Derivative Conversion · C | +67,031 | — | — | 863,031 |
| Gladstein Lana | General Counsel | May 04 | Derivative Conversion · C | +33,515 | — | — | 33,515 |
| Torres Denice | Director | May 04 | Derivative Conversion · C | +13,406 | — | — | 13,406 |
| Chen Michael Cunyuan | Chief Scientific Officer | May 04 | Derivative Conversion · C | +3,351 | — | — | 3,351 |
| White Lauren | Chief Financial Officer | May 04 | Derivative Conversion · C | +6,702 | — | — | 6,702 |
| PureTech Health plc | 10% owner | May 04 | Derivative Conversion · C | +965,255 | — | — | 16,685,013 |
| PureTech Health plc | 10% owner | May 04 | Derivative Conversion · C | +2,681,265 | — | — | 15,719,758 |
| PureTech Health plc | 10% owner | May 04 | Derivative Conversion · C | +12,736,014 | — | — | 13,038,493 |
Loading...